That is necessary, because the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. In other words, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (biotech stock). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're created to do. This was a development practically no one saw. But it's going to have profound ramifications for treating illness. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be a lot of investment chances in this area, too. Moving topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (tech stock). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it pulled back possibly considerably prior to going higher - tech predictions. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. But that's not the huge question anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. jeff brown biotech pick. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous great private companies on the edge of hitting the general public markets And I have actually been dealing with a new way for you to invest even before these companies go public.
This chance has actually been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to book your area for free.
Emma Walsh here, handling editor of the Journal. Regular Journal readers know that tech isn't our normal beat (tech stock). And when it pertains to tech investing, we leave it to the experts. Thankfully, we have a number of such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing specialists we know (what is the legacy report predicting). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential growth and developing amazing chances for investors. I want to make certain all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. future report. However in spite of what many readers may think, this is a pattern that's just starting. Even though the COVID-19 pandemic interrupted supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown investment prediction). Losing 2 months of manufacturing and sales truly impacts the number of 5G devices are sold in the calendar year. When you think about all of that, offering 250 million systems is impressive. More importantly, the delays caused by the pandemic developed a lot of bottled-up demand. And that demand is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown predictions for 2021. Which's not my only 5G forecast When I have actually talked about 5G in the past, I've described its three various stages.
In Stage Two, 5G devices go on sale. 5G phones and other items start to reach customers. And in Phase 3, 5G services begin to be provided (jeff brown stock predictions). That's when we start to see applications working on 5G networks. Believe of things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase Three by this summer. This begins something of a virtuous cycle: Most people do not truly appreciate the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In fact, 5G is going to open up a suite of unbelievable applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment chances moving forward will be huge. Stepping far from 5G, the next crucial technology I anticipate in 2021 is CRISPR genetic editing. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR utilizes a similar concept but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can fix these "typos." For several years, CRISPR was primarily a specific niche technology that wasn't well comprehended. And during that time, there were actually only three business running in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with illness and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering incredible returns. This whole market is effectively a greenfield chance.
There's space for lots of companies to exist in this space. brownstone research stock. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or 3 more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things occurring at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can accurately predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is very important since the way a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has been an experimental procedure. Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but several drug treatments produced utilizing this technology. This was among those breakthroughs that almost nobody saw. But it's going to have extensive ramifications for treating disease. And, of course, there will be a lot of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps substantially prior to going higher. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever released was on bitcoin - white house. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my recommendation. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. biotech stocks jeff brown. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info is up to date as of February 2021, however we might not independently validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to select winning innovation stocks. He invested more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an excellent viewpoint on the market. He's constantly on the hunt for new chances, and he shares a lot of his finest choices in the Near Future Report.
That's high praise, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully predicted a few of the greatest economic occasions of the previous 20 years. Although he doesn't appear to launch his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it right whenever, however Jeff Brown's precise forecasts have actually made him legions of devoted fans. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent financial research publisher. Brownstone Research study provides numerous research services with a wide variety of expertises - last week.
The company is also associated with Bonner & Partners, another well-respected research publisher - white house. On its site, Brownstone says its mission is to provide retail investors with professional-grade research: "For too long, the very best financial investment research study has not been available to individual investors. It has actually been generally booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. democratic republic. The objective of Brownstone Research study is to make that kind of exclusive research offered to any financiers looking to gain an edge in the marketplaces. The objective is simple to provide unique and successful investment research discovered no place else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also acts as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After years of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you understand even a little bit about the marketplace, you know that he has a track record as a King Midas of sorts. jeff brown genetic sequencer stock. Everything he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown believes S.A.V. brownstone research. could be "the greatest pattern of the 2020s, and he's not alone. Examine out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying 2 advanced innovations: expert system and electrical cars and trucks. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving automobiles ever. It's nothing short of the automotive industry's Holy Grail. As you understand, electric vehicles and self-driving automobile stocks have actually been big this year, however the Wall Street device has been big on buzz without much tangible result. Despite an extreme boost in competition over the past few years, Brown still believes Musk has the finest chance of putting it all together.
tech might be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Automobile, and it might be the future of transportation. Generally, this innovation would permit you to rent your car as a self-governing, self-driving taxi when you're not utilizing it. You merely leave the car and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a significant chunk of the earnings. It sounds insane, but it might be closed than you think.